{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:41:03Z","timestamp":1775234463834,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"vor","delay-in-days":1035,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/mtna.2014.60","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T16:18:51Z","timestamp":1415117931000},"page":"e209","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Inhibition of Monocyte Adhesion to Brain-Derived Endothelial Cells by Dual Functional RNA Chimeras"],"prefix":"10.1016","volume":"3","author":[{"given":"Jing","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhua","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiukuan","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mtna.2014.60_bib1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1189\/jlb.1109766","article-title":"Inflammatory mechanisms in ischemic stroke: role of inflammatory cells","volume":"87","author":"Jin","year":"2010","journal-title":"J Leukoc Biol."},{"key":"10.1038\/mtna.2014.60_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1742-2094-10-115","article-title":"Leukocyte infiltration in experimental stroke","volume":"10","author":"Gr\u00f8nberg","year":"2013","journal-title":"J Neuroinflammation"},{"key":"10.1038\/mtna.2014.60_bib3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1357-4310(97)01077-0","article-title":"The blood-brain barrier and the inflammatory response","volume":"3","author":"Perry","year":"1997","journal-title":"Mol Med Today"},{"key":"10.1038\/mtna.2014.60_bib4","first-page":"143","article-title":"Inflammation and stroke","volume":"12","author":"Benakis","year":"2008","journal-title":"Kardiovaskulare Medizin"},{"key":"10.1038\/mtna.2014.60_bib5","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.2174\/138161208786848766","article-title":"Inflammation as therapeutic objective in stroke","volume":"14","author":"Jordan","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1038\/mtna.2014.60_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4103\/0256-4947.83217","article-title":"Role of cell adhesion molecules in acute ischemic stroke","volume":"31","author":"Supanc","year":"2011","journal-title":"Ann Saudi Med"},{"key":"10.1038\/mtna.2014.60_bib7","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0891-5849(00)00223-9","article-title":"Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades","volume":"28","author":"Hubbard","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1038\/mtna.2014.60_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/01.STR.0000106479.53235.3E","article-title":"Inhibition of intercellular adhesion molecule-1 protein expression by antisense oligonucleotides is neuroprotective after transient middle cerebral artery occlusion in rat","volume":"35","author":"Vemuganti","year":"2004","journal-title":"Stroke"},{"key":"10.1038\/mtna.2014.60_bib9","first-page":"1309","article-title":"Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system","volume":"136","author":"Sobel","year":"1990","journal-title":"Am J Pathol"},{"key":"10.1038\/mtna.2014.60_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.4049\/jimmunol.178.2.851","article-title":"Intercellular adhesion molecule-1 expression is required on multiple cell types for the development of experimental autoimmune encephalomyelitis","volume":"178","author":"Bullard","year":"2007","journal-title":"J Immunol"},{"key":"10.1038\/mtna.2014.60_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-510X(91)90202-I","article-title":"Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease","volume":"106","author":"Frohman","year":"1991","journal-title":"J Neurol Sci"},{"key":"10.1038\/mtna.2014.60_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(92)90026-H","article-title":"Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55","volume":"36","author":"Fabry","year":"1992","journal-title":"J Neuroimmunol"},{"key":"10.1038\/mtna.2014.60_bib13","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1161\/01.STR.0000029008.00497.D3","article-title":"Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology?","volume":"33","author":"Blann","year":"2002","journal-title":"Stroke"},{"key":"10.1038\/mtna.2014.60_bib14","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.STR.0000074921.17767.F2","article-title":"Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation","volume":"34","author":"Ishikawa","year":"2003","journal-title":"Stroke"},{"key":"10.1038\/mtna.2014.60_bib15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/WNL.45.4.815","article-title":"Monoclonal antibodies preventing leukocyte activation reduce experimental neurologic injury and enhance efficacy of thrombolytic therapy","volume":"45","author":"Bowes","year":"1995","journal-title":"Neurology"},{"key":"10.1038\/mtna.2014.60_bib16","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1212\/WNL.44.9.1747","article-title":"Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat","volume":"44","author":"Zhang","year":"1994","journal-title":"Neurology"},{"key":"10.1038\/mtna.2014.60_bib17","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1212\/WNL.57.8.1428","article-title":"Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial","volume":"57","author":"Enlimomab Acute Stroke Trial Investigators","year":"2001","journal-title":"Neurology"},{"key":"10.1038\/mtna.2014.60_bib18","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1161\/hs3211.098535","article-title":"Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study","volume":"32","author":"Furuya","year":"2001","journal-title":"Stroke"},{"key":"10.1038\/mtna.2014.60_bib19","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1038\/mtna.2014.60_bib20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.cgt.7700857","article-title":"RNA interference and potential therapeutic applications of short interfering RNAs","volume":"12","author":"Karagiannis","year":"2005","journal-title":"Cancer Gene Ther"},{"key":"10.1038\/mtna.2014.60_bib21","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1038\/mtna.2014.60_bib22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0006-8993(00)03108-5","article-title":"Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin","volume":"889","author":"Zhang","year":"2001","journal-title":"Brain Res."},{"key":"10.1038\/mtna.2014.60_bib23","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1073\/pnas.90.7.2618","article-title":"Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery","volume":"90","author":"Bickel","year":"1993","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1038\/mtna.2014.60_bib24","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1023\/B:PHAM.0000003375.13655.f9","article-title":"Absence of toxicity of chronic weekly intravenous gene therapy with pegylated immunoliposomes","volume":"20","author":"Zhang","year":"2003","journal-title":"Pharm Res."},{"key":"10.1038\/mtna.2014.60_bib25","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/bit.21369","article-title":"Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier","volume":"97","author":"Boado","year":"2007","journal-title":"Biotechnol Bioeng"},{"key":"10.1038\/mtna.2014.60_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1525-0016(02)00018-7","article-title":"Global non-viral gene transfer to the primate brain following intravenous administration","volume":"7","author":"Zhang","year":"2003","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2014.60_bib27","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1073\/pnas.0711714105","article-title":"Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers","volume":"105","author":"Gu","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1038\/mtna.2014.60_bib28","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1038\/mtna.2014.60_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"10.1038\/mtna.2014.60_bib30","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4049\/jimmunol.132.2.872","article-title":"Responsiveness of autoimmune and normal mice to nucleic acid antigens","volume":"132","author":"Madaio","year":"1984","journal-title":"J Immunol"},{"key":"10.1038\/mtna.2014.60_bib31","doi-asserted-by":"crossref","first-page":"15908","DOI":"10.1073\/pnas.0808360105","article-title":"Aptamer-based endocytosis of a lysosomal enzyme","volume":"105","author":"Chen","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1038\/mtna.2014.60_bib32","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.gt.3302856","article-title":"Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells","volume":"13","author":"Guo","year":"2006","journal-title":"Gene Ther"},{"key":"10.1038\/mtna.2014.60_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0378-1119(03)00729-7","article-title":"Gene cloning, purification, and stoichiometry quantification of phi29 anti-receptor gp12 with potential use as special ligand for gene delivery","volume":"315","author":"Guo","year":"2003","journal-title":"Gene"},{"key":"10.1038\/mtna.2014.60_bib34","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1089\/hum.2005.16.1097","article-title":"Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA","volume":"16","author":"Guo","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtna.2014.60_bib35","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt1223","article-title":"Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras","volume":"24","author":"McNamara 2nd","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mtna.2014.60_bib36","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1021\/nl051264s","article-title":"Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology","volume":"5","author":"Khaled","year":"2005","journal-title":"Nano Lett"},{"key":"10.1038\/mtna.2014.60_bib37","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1016\/j.febslet.2005.08.070","article-title":"Approaches for chemically synthesized siRNA and vector-mediated RNAi","volume":"579","author":"Amarzguioui","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1038\/mtna.2014.60_bib38","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1093\/nar\/gki732","article-title":"Functional polarity is introduced by Dicer processing of short substrate RNAs","volume":"33","author":"Rose","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1038\/mtna.2014.60_bib39","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nprot.2006.72","article-title":"Rational design and in vitro and in vivo delivery of Dicer substrate siRNA","volume":"1","author":"Amarzguioui","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1038\/mtna.2014.60_bib40","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/mt.2010.243","article-title":"Application of phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancers","volume":"19","author":"Tarapore","year":"2011","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2014.60_bib41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/(SICI)1096-9861(19961125)375:4<675::AID-CNE8>3.0.CO;2-Z","article-title":"Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system","volume":"375","author":"Moos","year":"1996","journal-title":"J Comp Neurol"},{"key":"10.1038\/mtna.2014.60_bib42","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s11095-007-9389-y","article-title":"Targeted delivery of complexes of biotin-PEG-polyethylenimine and NF-kappaB decoys to brain-derived endothelial cells in vitro","volume":"25","author":"Bhattacharya","year":"2008","journal-title":"Pharm Res."},{"key":"10.1038\/mtna.2014.60_bib43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1179\/016164103101201508","article-title":"Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin","volume":"25","author":"Omori","year":"2003","journal-title":"Neurol Res."},{"key":"10.1038\/mtna.2014.60_bib44","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.biochi.2005.04.013","article-title":"Aptamers against extracellular targets for in vivo applications","volume":"87","author":"Pestourie","year":"2005","journal-title":"Biochimie"},{"key":"10.1038\/mtna.2014.60_bib45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev.med.56.062904.144915","article-title":"Aptamers: an emerging class of therapeutics","volume":"56","author":"Nimjee","year":"2005","journal-title":"Annu Rev Med"},{"key":"10.1038\/mtna.2014.60_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/viro.1994.1267","article-title":"The proximate 5\u2019 and 3\u2019 ends of the 120-base viral RNA (pRNA) are crucial for the packaging of bacteriophage phi 29 DNA.","volume":"201","author":"Zhang","year":"1994","journal-title":"Virology"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116303481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116303481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T20:59:23Z","timestamp":1689627563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253116303481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":46,"alternative-id":["S2162253116303481"],"URL":"https:\/\/doi.org\/10.1038\/mtna.2014.60","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"article-number":"e209"}}